BioLineRx (BLRX) Return on Equity [ROE] (2011 - 2026)
BioLineRx's Return on Equity [ROE] was -59.88% in the quarter ended Jun 30, 2026, down 18.09 percentage points from -41.79% a year earlier and down 10.92 percentage points from the prior quarter.
Powered by 
Analysis
BioLineRx (BLRX) Return on Equity [ROE] (2011 - 2026) Analysis & Trends
For the year ended Dec 31, 2025, Return on Equity [ROE] at BioLineRx came in at -11.01%, up 58.10 percentage points from the prior year.
- Return on Equity [ROE] shows a five-year change of +97.35 percentage points (years ended Dec 2020 to Dec 2025).
- In earlier years, Return on Equity [ROE] was -69.11% in the year ended Dec 31, 2024 (+120.12 pp), -189.23% in the year ended Dec 31, 2023 (-147.27 pp), -41.96% in the year ended Dec 31, 2022 (+18.08 pp) and -60.04% in the year ended Dec 31, 2021 (+48.32 pp).
- The figure for the quarter ended Jun 30, 2026 marks the lowest quarterly Return on Equity [ROE] since the quarter ended Sep 30, 2024.
- Compared with a year earlier, Return on Equity [ROE] has declined for three straight quarters, with an average year-over-year change of +143.98 percentage points over the last eight quarters.
- The best year-over-year quarter for Return on Equity [ROE] over five years was the quarter ended Dec 31, 2024 (a gain of 431.43 percentage points); the worst was the quarter ended Dec 31, 2023 (a drop of 411.76 percentage points).
- Per Business Quant data, BLRX's Return on Equity [ROE] in the three quarters before the quarter ended Jun 30, 2026 was -48.96% (quarter ended Mar 31, 2026), -46.39% (quarter ended Dec 31, 2025) and -34.10% (quarter ended Sep 30, 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROE (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,261.99 Bn | 1,235.61 Bn | 20.46 Bn | 74.39% |
| 2 | Johnson & Johnson | 678.93 Bn | 598.79 Bn | 17.30 Bn | 19.33% |
| 3 | AbbVie | 518.29 Bn | 486.30 Bn | 13.12 Bn | - |
| 4 | Merck | 365.98 Bn | 328.92 Bn | 13.19 Bn | 5.63% |
| 5 | Novartis Ag | 316.85 Bn | 290.09 Bn | - | - |
| 6 | Astrazeneca | 293.40 Bn | 267.29 Bn | 13.26 Bn | 21.60% |
| 7 | Amgen | 251.78 Bn | 203.43 Bn | 7.58 Bn | 72.13% |
| 8 | Gilead Sciences | 210.61 Bn | 185.71 Bn | 6.73 Bn | -31.17% |
| 9 | Pfizer | 166.87 Bn | 114.23 Bn | 12.56 Bn | 4.66% |
| 10 | BioLineRx | 6.74 Mn | -69.78 Mn | 235,000.00 | -157.81% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -157.81% |
| Mar 31, 2026 | -122.25% |
| Dec 31, 2025 | -66.29% |
| Sep 30, 2025 | -126.20% |
| Jun 30, 2025 | -130.90% |
| Mar 31, 2025 | -130.34% |
| Dec 31, 2024 | -218.69% |
| Sep 30, 2024 | -259.98% |
| Jun 30, 2024 | -274.46% |
| Mar 31, 2024 | -427.18% |
| Dec 31, 2023 | -456.82% |
| Sep 30, 2023 | -281.36% |
| Jun 30, 2023 | -144.89% |
| Mar 31, 2023 | -72.23% |
| Dec 31, 2022 | -58.14% |
| Sep 30, 2022 | -50.17% |
| Jun 30, 2022 | -45.54% |
| Mar 31, 2022 | -40.64% |
| Dec 31, 2021 | -37.31% |
| Sep 30, 2021 | -36.42% |
API Access
BioLineRx Return on Equity [ROE] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=BLRX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-equity-[roe]", "ticker": "BLRX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=BLRX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();